A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
Erica Brivio(Princess Máxima Center), C. Michel Zwaan(Princess Máxima Center), Claudia Rössig(Klinik und Poliklinik für Kinder- und Jugendmedizin), Ingrid Øra(Karolinska University Hospital), Inge M. van der Sluis(Princess Máxima Center), Franco Locatelli(Bambino Gesù Children's Hospital), Vincent H. J. van der Velden(Erasmus MC), Christiane Chen‐Santel(Universitätsmedizin Rostock), Adriana Thano(The Netherlands Cancer Institute), Monique L. den Boer(Princess Máxima Center), Luciana Vinti(Bambino Gesù Children's Hospital), Anneke C. J. Ammerlaan(Princess Máxima Center), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Lucie Šrámková(University Hospital in Motol), Bella Bielorai, Karsten Nysom(Copenhagen University Hospital), Ying Chen(Pfizer (United States)), Barbara Sleight(Pfizer (United States)), Marta López‐Yurda(The Netherlands Cancer Institute), Andrea Malone(Children's Health Ireland at Crumlin), Benoît Brethon(Hôpital Saint-Louis)
Cited by 93
Related Papers
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment
|New England Journal of Medicine|2004|645